Atherosclerosis
Volume 148, Issue 1 , Pages 141-149 , January 2000

Low density lipoprotein particle size and risk factors of insulin resistance syndrome

  • Yechiel Friedlander

      Affiliations

    • The Department of Social Medicine, The Hebrew University-Hadassah School of Public Health, POB 12272, Jerusalem 91120, Israel
    • Corresponding Author InformationCorresponding author. Tel.: +972-2-677-7115; fax: +972-2-643-1086
    • ,
  • Miriam Kidron

      Affiliations

    • The Diabetes Unit, Division of Medicine, The Hadassah University Hospital, Jerusalem, Israel
    • ,
  • Muriel Caslake

      Affiliations

    • The Department of Pathological Biochemistry, The University of Glasgow, Glasgow, Scotland, UK
    • ,
  • Tracey Lamb

      Affiliations

    • The Department of Pathological Biochemistry, The University of Glasgow, Glasgow, Scotland, UK
    • ,
  • Michael McConnell

      Affiliations

    • The Department of Pathological Biochemistry, The University of Glasgow, Glasgow, Scotland, UK
    • ,
  • Hanoch Bar-On

      Affiliations

    • The Diabetes Unit, Division of Medicine, The Hadassah University Hospital, Jerusalem, Israel

Received 26 February 1999 ,Revised 7 May 1999 ,Accepted 2 June 1999.

References 

  1. Crouse JR, Parks JS, Schey HM. Studies of low density lipoprotein molecular weight in human beings with coronary artery disease. J. Lipid Res. 1985;26:566–574
  2. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WS, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. J. Am. Med. Assoc. 1988;260:1917–1921
  3. Campos H, Genest JJ, Blijlevens E, McNamara JR, Jenner JL, Ordovas JM, et al. Low density lipoprotein particle size and coronary artery disease. Arterioscler. Thromb. 1992;12:187–195
  4. Gardner CD, Fortmann SP, Krauss RM. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. J. Am. Med. Assoc. 1996;276:875–881
  5. Stampfer MJ, Krauss RM, Ma J, Blanche PJ, Holl LG, Sacks FM, et al. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. J. Am. Med. Assoc. 1996;276:882–888
  6. Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Circulation. 1997;95:69–75
  7. Swinkels DWL, Demacker PNM, Hendriks JCM, van’t Laar A. Low density lipoprotein subfraction and relationship to other risk factors for coronary artery disease in healthy individuals. Arteriosclerosis. 1989;9:904–913
  8. Austin MA, King M-C, Vranzian KM, Krauss RM. Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease risk. Circulation. 1990;82:495–506
  9. McNamara JR, Jenner JL, Li Z, Wilson PWF, Schafer EJ. Change in LDL particle size is associated with change in plasma triglyceride concentration. Arterioscler. Thromb. 1992;12:1284–1290
  10. Haffner SM, Mtkkanen L, Valdez RA, Paidi M, Stern MP, Howard BV. LDL size and subclass pattern in a biethnic population. Arterioscler. Thromb. 1993;13:1628–1630
  11. Stout RW. Insulin and atheroma: 20-yr prespective. Diabetes Care. 1990;13:631–654
  12. Eschwege E, Richard JL, Thibult N, Ducimetiere P, Warnet JM, Claude JR, et al. Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels: the Paris Prospective Study, 10 years later. Horm. Metab. Res. Suppl. 1985;15:41–46
  13. Pyorala K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: Results from two population studies in Finland. Diabetes Care. 1979;2:131–141
  14. Pyorala K, Savolainen E, Kaukola S, Haapakoski J. Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9 1/2 year follow-up of the Helsinki Policemen Study Population. Acta Med. Scand. (Suppl.). 1985;701:38–52
  15. Ducimetiere P, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia. 1980;19:205–210
  16. Welborn TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care. 1979;2:154–160
  17. Cullen K, Stenhouse NS, Wearne KL, Welborn TA. Multiple regression analysis of risk factors for cardiovascular disease and cancer mortality in Basselton, Western Australia—13-year study. J. Chron. Dis. 1983;36:371–377
  18. Hargreaves AD, Logan RL, Elton RA, Buchanan KD, Oliver MF, Riemersma RA. Glucose tolerance, plasma insulin, HDL cholesterol and obesity: 12-year follow-up and development of coronary heart disease in Edinburgh men. Atherosclerosis. 1992;94:61–69
  19. Yarnell JW, Sweetnam PM, Marks V, Teale JD, Bolton CH. Insulin in ischaemic heart disease: are associations explained by triglyceride concentrations? The Caerphilly prospective study. Br. Heart J. 1994;71:293–296
  20. Orchard TJ, Eichner J, Kuller LH, Becker DJ, McCallum LM, Grandits GA. Insulin as a predictor of coronary heart disease: interaction with apolipoprotein E phenotype: a report from the Multiple Risk Factor Intervention Trial. Ann. Epidemiol. 1994;4:40–45
  21. Reaven GM. Role of insulin resistance in human disease. Banting lecture 1988. Diabetes. 1988;37:1595–1607
  22. Barakat HA, Carpenter JW, McLendon VD, Khazanie P, Legget N, Heath J, et al. Influence of obesity, impared glucose tolerance, and NIDDM on LDL structure and composition: possible link between hyperinsulinemia and atherosclerosis. Diabetes. 1990;39:1527–1533
  23. Barakat HA, Marks R. Association of small LDL particles with hyperinsulinemia. Arteriosclerosis. 1989;9:725a
  24. Selby JV, Austin MA, Newman B, Zhang D, Quesenberry CP, Mayer EJ, et al. LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation. 1993;88:381–387
  25. Reaven GM, Chen Y-DI, Jeppesen J, Maheux P, Krauss RM. Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles. J. Clin. Invest. 1993;92:141–146
  26. Haffner SM, Mykkanen L, Robbins D, Valdez R, Miettinen H, Howard BV, et al. Preponderance of small dense LDL is associated with specific insulin, proinsulin and the components of the insulin resistance syndrome in non-diabetic subjects. Diabetologia. 1995;38:1328–1336
  27. Terry RB, Wood PD, Haskell WL, Stefanick ML, Krauss RM. Regional adiposity pattern in relation to lipids, lipoprotein cholesterol, and lipoprotein subfraction mass in men. Clin. Endocrinol. Metab. 1989;68:191–199
  28. Bar-On H, Friedlander Y, Kidron M, Kark JD. Serum glucose and insulin characteristics and prevalence of diabetes mellitus and impaired glucose tolerance in adult Jewish population of Jerusalem. The Jerusalem Diabetes Prevalence Study. Nutr. Metab. Cardiovasc. Dis. 1992;2:75–81
  29. Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma-without use of preparative ultracentrifuge. Clin. Chem. 1972;18:449–502
  30. Friedlander Y, Kark JD, Eisenberg S, Stein Y. Calculation of LDL-cholesterol from total cholesterol, triglyceride and HDL-cholesterol: a comparison of methods in the Jerusalem Lipid Research Clinic prevalence study. Isr. J. Med. Sci. 1982;18:1242–1252
  31. Nichols AV, Krauss RM, Musliner TA. Non-denaturing polyacrylamide gradient gel electrophoresis. Methods Enzymol. 1982;128:417–431
  32. Griffin BA, Caslake MJ, Yip B, Tait GW, Packard CJ, Shepherd J. Rapid isolation of low density lipoprotein (LDL) subfractions from plasma by density gradient ultracentrifugation. Atherosclerosis. 1990;83:59–67
  33. Karlin S, Carmelli D, Williams PT, Friedlander Y, Colen T, Stein Y. Association of arrays for comparing familial total cholesterol, high density lipoprotein cholesterol, and triglyceride similarity in the Israeli population by country of origin. Am. J. Epidemiol. 1982;116:1022–1032
  34. Karlin S. The method of association arrays in assessing forms of dependencies between bivariate random variables. Proc. Natl. Acad. Sci. USA. 1983;80:647–651
  35. Hollenbeck C, Reaven GM. Variations in insulin-stimulated glucose uptake in individuals with normal glucose tolerance. J. Clin. Endocrinol. Metab. 1987;64:1169–1173
  36. Laakso M. How good a marker is insulin level for insulin resistance?. Am. J. Epidemiol. 1993;137:959–965
  37. Saad MF, Anderson RL, Laws A, Watanabe RM, Kades WW, Chen YDI, et al. A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Diabetes. 1994;43:1114–1121
  38. Austin MA, Selby JV. LDL subclass phenotypes and the risk factors of the insulin resistance syndrome. Int. J. Obes. 1995;19(Suppl. 1):S22–S26
  39. Mykkanen L, Haffner SM, Rainwater DL, Karhapaa P, Miettinen H, Laakso M. Relationship of LDL size to insulin sensitivity in normoglycemic men. Arterioscler. Thromb. Vasc. Biol. 1997;17:1447–1453
  40. Slyper AH, Zvereva S, Schectman G, Hoffmann RG, Mueller RA, Walker JA. Insulin resistance is not a major determinant of low-density lipoprotein particle size. Metabolism. 1997;46:1275–1280
  41. Gray RS, Robbins DC, Wang W, Yeh JL, Fabsitz RR, Cowan LD, et al. Relation of LDL size to the insulin resistance syndrome and coronary heart disease in American Indians. The Strong Heart Study. Arterioscler. Thromb. Vasc. Biol. 1997;17:2713–2720
  42. Ambrosch A, Muhlen I, Kopf D, Augustin W, Dierkes J, Konig W, et al. LDL size distribution in relation to insulin sensitivity and lipoprotein pattern in young and health subjects. Diabetes Care. 1998;21:2077–2084
  43. Tchernof A, Lamarche B, Prud’homme D, Nadeau A, Moorjani S, Labrie F, et al. The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men. Diabetes Care. 1996;19:629–637
  44. Slyper AH, Zvereva S, Schectman G, Hoffmann RG, Mueller RA, Walker JA. Insulin resistance is not a major determinant of low-density lipoprotein particle size. Metabolism. 1997;46:1275–1280
  45. Austin MA. Low density lipoprotein subclass phenotypes. In:  Goldbourt U,  de Faire U,  Berg K editor. Genetic Factors in Coronary Heart Disease. London: Kluwer Academic; 1994;p. 105–113
  46. Reaven GM, Lerner RL, Stern MP, Farquhar JW. Role of insulin in endogenous hypertriglyceridemia. J. Clin. Invest. 1967;46:1756–1767
  47. Tobey TA, Greenfield MS, Kraemer F, Reaven GM. Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics and plasma triglyceride levels in normotriglyceridemic man. Metabolism. 1981;30:165–171
  48. Reaven GM. Abnormal lipoprotein metabolism in non-insulin-dependent diabetes mellitus. Athogenesis and treatment. Am. J. Med. 1987;83(Suppl. 3A):31–40
  49. Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardivascular risk factor. Am. J. Cardiol. 1998;81(4A):7B–12B
  50. Fontbonne AM, Eschwege EM. Insulin and cardiovascular disease. Paris Prospective Study. Diabetes Care. 1991;14:461–469
  51. Castelli WP. The triglyceride issue: a view from Framingham. Am. Heart. J. 1986;112:432–437
  52. McNamara JR, Campos H, Ordovas JM, Peterson J, Wilson PWF, Schaefer EJ. Effect of gender,age, and lipid status on low density lipoprotein subfraction distribution: results from the Framingham Offspring Study. Arteriosclerosis. 1987;7:484–490
  53. Austin MA, Brunzell JD, Fitch WL, Krauss RM. Inheritance of low density lipoprotein subclass pattern in familial combined hyperlipidemia. Arteriosclerosis. 1990;10:520–530
  54. Campos H, Genest JJ, Blijlevens E, McNamara JR, Ordovas JM, Posner BM, et al. LDL particle distribution. Results from the Framingham Offspring Study. Arterioscler. Thromb. 1992;12:1410–1419
  55. Williams PT, Krauss RM, Vranizan KM, Wood PDS. Changes in lipoprotein subfraction during diet-induced and exercise-induced weight loss in moderately overweight men. Circulation. 1990;81:1293–1304
  56. Dreon DM, Fernstrom HA, Miller B, Krauss RM. Low-density lipoprotein subclass pattern and lipoprotein response to a reduced-fat diet in men. FASEB J. 1994;8:121–126
  57. Superko HR, Krauss RM. Differential effects of nicotinic acid in subjects with different LDL subclass patterns. Atherosclerosis. 1992;95:69–76

PII: S0021-9150(99)00215-4

Atherosclerosis
Volume 148, Issue 1 , Pages 141-149 , January 2000

Article Tools